IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Belanger who wrote (1169)	7/26/1997 1:59:00 PM
From: aknahow	of 1762

Try the N.Y. Times on line. In e-mail version nice article. $200 million potential U.S. market. Other monoclonal antibody products such as anti-artharitics, & psorasis mentioned as possible by IDEC. O.K. try link nytimes.com May have to register its free. If it does not work will post later. Does not work try business section nytimes.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next